| # | Drug | Count |
|---|---|---|
| 0 | ECULIZUMAB | 28 |
| 1 | BELIMUMAB | 14 |
| 2 | PREDNISONE | 9 |
| 3 | RAVULIZUMAB | 5 |
| 4 | CYCLOSPORINE | 4 |
| 5 | ADALIMUMAB | 3 |
| 6 | LEVOTHYROXINE SODIUM | 3 |
| 7 | RITUXIMAB | 3 |
| 8 | APIXABAN | 2 |
| 9 | CARBOPLATIN | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DELANDISTROGENE MOXEPARVOVEC-ROKL | 1 | 0.0027 |
| 1 | MAGNESIUM SALICYLATE | 1 | 0.0017 |
| 2 | GIVINOSTAT | 1 | 0.0016 |
| 3 | BETAINE | 1 | 0.0010 |
| 4 | CRIZANLIZUMAB | 1 | 0.0007 |
| 5 | PEGCETACOPLAN | 1 | 0.0005 |
| 6 | ECULIZUMAB | 28 | 0.0005 |
| 7 | TRANDOLAPRIL TABLETS | 1 | 0.0005 |
| 8 | PROPYLTHIOURACIL | 1 | 0.0005 |
| 9 | BELIMUMAB | 14 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Methylating Agent [EPC] | 1 | 0.0010 |
| 1 | Selectin Blocker [EPC] | 1 | 0.0007 |
| 2 | Complement Inhibitor [EPC] | 29 | 0.0005 |
| 3 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 14 | 0.0004 |
| 4 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 5 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 6 | Histone Deacetylase Inhibitor [EPC] | 1 | 0.0003 |
| 7 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 8 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 9 | Typical Antipsychotic [EPC] | 1 | 0.0000 |